25 XP   0   0   10

Hainan Shuangcheng Pharmaceut
Buy, Hold or Sell?

Let's analyse Hainan Shuangcheng Pharmaceut together

PenkeI guess you are interested in Hainan Shuangcheng Pharmaceut. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hainan Shuangcheng Pharmaceut. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hainan Shuangcheng Pharmaceut

I send you an email if I find something interesting about Hainan Shuangcheng Pharmaceut.

Quick analysis of Hainan Shuangcheng Pharmaceut (30 sec.)










What can you expect buying and holding a share of Hainan Shuangcheng Pharmaceut? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥1.38
Expected worth in 1 year
¥1.40
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
¥0.03
Return On Investment
0.6%

For what price can you sell your share?

Current Price per Share
¥5.26
Expected price per share
¥3.67 - ¥6.88
How sure are you?
50%

1. Valuation of Hainan Shuangcheng Pharmaceut (5 min.)




Live pricePrice per Share (EOD)

¥5.26

Intrinsic Value Per Share

¥-1.74 - ¥-2.08

Total Value Per Share

¥-0.36 - ¥-0.69

2. Growth of Hainan Shuangcheng Pharmaceut (5 min.)




Is Hainan Shuangcheng Pharmaceut growing?

Current yearPrevious yearGrowGrow %
How rich?$79.6m$78.8m$1.6m2.1%

How much money is Hainan Shuangcheng Pharmaceut making?

Current yearPrevious yearGrowGrow %
Making money$380.1k-$687.4k$1m280.8%
Net Profit Margin1.3%-7.4%--

How much money comes from the company's main activities?

3. Financial Health of Hainan Shuangcheng Pharmaceut (5 min.)




What can you expect buying and holding a share of Hainan Shuangcheng Pharmaceut? (5 min.)

Welcome investor! Hainan Shuangcheng Pharmaceut's management wants to use your money to grow the business. In return you get a share of Hainan Shuangcheng Pharmaceut.

What can you expect buying and holding a share of Hainan Shuangcheng Pharmaceut?

First you should know what it really means to hold a share of Hainan Shuangcheng Pharmaceut. And how you can make/lose money.

Speculation

The Price per Share of Hainan Shuangcheng Pharmaceut is ¥5.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hainan Shuangcheng Pharmaceut.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hainan Shuangcheng Pharmaceut, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.38. Based on the TTM, the Book Value Change Per Share is ¥0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hainan Shuangcheng Pharmaceut.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.00-0.1%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share0.00-0.1%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share1.06-0.95-0.72-0.72-1.01-
Price to Earnings Ratio-76.44-71.30-39.43--6.51-24.01-
Price-to-Total Gains Ratio-235.57-277.85-58.31--19.08--69.94-
Price to Book Ratio5.52-4.95-3.81-3.59-4.24-
Price-to-Total Gains Ratio-235.57-277.85-58.31--19.08--69.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.726406
Number of shares1376
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1376 shares)1.52-2.02
Gains per Year (1376 shares)6.06-8.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
142-44-12-18
28429-25-26
3126813-37-34
41681418-50-42
520102022-62-50
624132626-75-58
728153231-87-66
832173835-100-74
936194439-112-82
1040215044-125-90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%5.07.00.041.7%6.014.00.030.0%17.016.07.042.5%22.016.07.048.9%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%6.014.00.030.0%15.025.00.037.5%19.026.00.042.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%41.00.04.091.1%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%7.013.00.035.0%19.021.00.047.5%24.021.00.053.3%

Fundamentals of Hainan Shuangcheng Pharmaceut

About Hainan Shuangcheng Pharmaceut

Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 18:54:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hainan Shuangcheng Pharmaceut.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hainan Shuangcheng Pharmaceut earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -24.1% means that ¥-0.24 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is -24.1%. The company is making a huge loss. -2
  • The TTM is 1.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM1.3%-25.4%
TTM1.3%YOY-7.4%+8.8%
TTM1.3%5Y-5.9%+7.2%
5Y-5.9%10Y3.8%-9.7%
1.1.2. Return on Assets

Shows how efficient Hainan Shuangcheng Pharmaceut is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Assets means that Hainan Shuangcheng Pharmaceut generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM0.3%-1.5%
TTM0.3%YOY-0.6%+0.9%
TTM0.3%5Y-0.4%+0.7%
5Y-0.4%10Y0.1%-0.5%
1.1.3. Return on Equity

Shows how efficient Hainan Shuangcheng Pharmaceut is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.0% Return on Equity means Hainan Shuangcheng Pharmaceut generated ¥-0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is -2.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM0.5%-2.5%
TTM0.5%YOY-1.0%+1.6%
TTM0.5%5Y-0.8%+1.3%
5Y-0.8%10Y-0.1%-0.8%

1.2. Operating Efficiency of Hainan Shuangcheng Pharmaceut.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hainan Shuangcheng Pharmaceut is operating .

  • Measures how much profit Hainan Shuangcheng Pharmaceut makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -39.6% means the company generated ¥-0.40  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is -39.6%. The company is operating very inefficient. -2
  • The TTM is -12.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.6%TTM-12.8%-26.9%
TTM-12.8%YOY-18.9%+6.1%
TTM-12.8%5Y-13.2%+0.5%
5Y-13.2%10Y-7.5%-5.7%
1.2.2. Operating Ratio

Measures how efficient Hainan Shuangcheng Pharmaceut is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.66 means that the operating costs are ¥1.66 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is 1.658. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.429. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.658TTM1.429+0.229
TTM1.429YOY1.446-0.016
TTM1.4295Y1.424+0.006
5Y1.42410Y0.968+0.455

1.3. Liquidity of Hainan Shuangcheng Pharmaceut.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hainan Shuangcheng Pharmaceut is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.74 means the company has ¥0.74 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is 0.743. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.794. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.743TTM0.794-0.052
TTM0.794YOY1.862-1.068
TTM0.7945Y1.766-0.972
5Y1.76610Y1.038+0.727
1.3.2. Quick Ratio

Measures if Hainan Shuangcheng Pharmaceut is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.43 means the company can pay off ¥0.43 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is 0.431. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.485. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.431TTM0.485-0.054
TTM0.485YOY1.152-0.667
TTM0.4855Y1.044-0.560
5Y1.04410Y0.817+0.228

1.4. Solvency of Hainan Shuangcheng Pharmaceut.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hainan Shuangcheng Pharmaceut assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hainan Shuangcheng Pharmaceut to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Hainan Shuangcheng Pharmaceut assets are financed with 33.0% credit (debt) and the remaining percentage (100% - 33.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is 0.330. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.346. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.330TTM0.346-0.016
TTM0.346YOY0.353-0.006
TTM0.3465Y0.334+0.012
5Y0.33410Y0.325+0.009
1.4.2. Debt to Equity Ratio

Measures if Hainan Shuangcheng Pharmaceut is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 54.2% means that company has ¥0.54 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The MRQ is 0.542. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.591. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.542TTM0.591-0.050
TTM0.591YOY0.633-0.042
TTM0.5915Y0.603-0.011
5Y0.60310Y0.609-0.006

2. Market Valuation of Hainan Shuangcheng Pharmaceut

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hainan Shuangcheng Pharmaceut generates.

  • Above 15 is considered overpriced but always compare Hainan Shuangcheng Pharmaceut to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -76.44 means the investor is paying ¥-76.44 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The EOD is -52.625. Based on the earnings, the company is expensive. -2
  • The MRQ is -76.436. Based on the earnings, the company is expensive. -2
  • The TTM is 71.299. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-52.625MRQ-76.436+23.811
MRQ-76.436TTM71.299-147.736
TTM71.299YOY39.426+31.873
TTM71.2995Y-6.515+77.814
5Y-6.51510Y24.009-30.524
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The EOD is -28.976. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -42.087. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.795. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.976MRQ-42.087+13.111
MRQ-42.087TTM-23.795-18.291
TTM-23.795YOY-23.077-0.719
TTM-23.7955Y-24.859+1.064
5Y-24.85910Y-22.145-2.714
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hainan Shuangcheng Pharmaceut is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hainan Shuangcheng Pharmaceut:

  • The EOD is 3.799. Based on the equity, the company is fair priced.
  • The MRQ is 5.518. Based on the equity, the company is overpriced. -1
  • The TTM is 4.947. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.799MRQ5.518-1.719
MRQ5.518TTM4.947+0.571
TTM4.947YOY3.812+1.135
TTM4.9475Y3.588+1.359
5Y3.58810Y4.239-0.652
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hainan Shuangcheng Pharmaceut compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0340.003-1337%-0.008-75%-0.016-52%-0.016-52%
Book Value Per Share--1.3851.398-1%1.370+1%1.468-6%1.707-19%
Current Ratio--0.7430.794-6%1.862-60%1.766-58%1.038-28%
Debt To Asset Ratio--0.3300.346-5%0.353-6%0.334-1%0.325+2%
Debt To Equity Ratio--0.5420.591-8%0.633-14%0.603-10%0.609-11%
Dividend Per Share--0.0020.005-68%0.006-73%0.006-71%0.026-94%
Eps---0.0250.007-478%-0.012-52%-0.009-62%0.003-921%
Free Cash Flow Per Share---0.045-0.022-52%-0.018-61%-0.010-77%-0.089+96%
Free Cash Flow To Equity Per Share---0.123-0.040-67%-0.016-87%-0.033-73%-0.025-80%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.825+21%
Intrinsic Value_10Y_max---2.076--------
Intrinsic Value_10Y_min---1.741--------
Intrinsic Value_1Y_max---0.072--------
Intrinsic Value_1Y_min---0.070--------
Intrinsic Value_3Y_max---0.319--------
Intrinsic Value_3Y_min---0.303--------
Intrinsic Value_5Y_max---0.692--------
Intrinsic Value_5Y_min---0.634--------
Market Cap2191479102.080-45%3183061527.6002879961999.420+11%2175855439.280+46%2176480417.116+46%3058069531.227+4%
Net Profit Margin---0.2410.013-1908%-0.074-69%-0.059-75%0.038-736%
Operating Margin---0.396-0.128-68%-0.189-52%-0.132-67%-0.075-81%
Operating Ratio--1.6581.429+16%1.446+15%1.424+16%0.968+71%
Pb Ratio3.799-45%5.5184.947+12%3.812+45%3.588+54%4.239+30%
Pe Ratio-52.625+31%-76.43671.299-207%39.426-294%-6.515-91%24.009-418%
Price Per Share5.260-45%7.6406.913+11%5.223+46%5.224+46%7.340+4%
Price To Free Cash Flow Ratio-28.976+31%-42.087-23.795-43%-23.077-45%-24.859-41%-22.145-47%
Price To Total Gains Ratio-162.187+31%-235.572277.849-185%58.312-504%-19.075-92%-69.945-70%
Quick Ratio--0.4310.485-11%1.152-63%1.044-59%0.817-47%
Return On Assets---0.0120.003-517%-0.006-52%-0.004-67%0.001-1272%
Return On Equity---0.0200.005-469%-0.010-48%-0.008-59%-0.001-97%
Total Gains Per Share---0.0320.008-507%-0.002-94%-0.011-67%0.010-421%
Usd Book Value--79663998.89380465029.989-1%78808504.262+1%84471135.831-6%98202127.393-19%
Usd Book Value Change Per Share---0.0050.000-1337%-0.001-75%-0.002-52%-0.002-52%
Usd Book Value Per Share--0.1910.193-1%0.189+1%0.203-6%0.236-19%
Usd Dividend Per Share--0.0000.001-68%0.001-73%0.001-71%0.004-94%
Usd Eps---0.0030.001-478%-0.002-52%-0.001-62%0.000-921%
Usd Free Cash Flow---2611172.407-1242773.773-52%-1018181.306-61%-598460.480-77%-4218433.307+62%
Usd Free Cash Flow Per Share---0.006-0.003-52%-0.002-61%-0.001-77%-0.012+96%
Usd Free Cash Flow To Equity Per Share---0.017-0.006-67%-0.002-87%-0.005-73%-0.003-80%
Usd Market Cap302643263.997-45%439580796.962397722752.120+11%300485636.165+46%300571945.604+46%422319402.262+4%
Usd Price Per Share0.726-45%1.0550.955+11%0.721+46%0.721+46%1.014+4%
Usd Profit---1437734.772380193.593-478%-687452.055-52%-542803.728-62%175197.869-921%
Usd Revenue--5970817.8278946798.865-33%9229797.424-35%10160904.353-41%8867209.510-33%
Usd Total Gains Per Share---0.0040.001-507%0.000-94%-0.001-67%0.001-421%
 EOD+3 -5MRQTTM+7 -28YOY+10 -255Y+7 -2810Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Hainan Shuangcheng Pharmaceut based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-52.625
Price to Book Ratio (EOD)Between0-13.799
Net Profit Margin (MRQ)Greater than0-0.241
Operating Margin (MRQ)Greater than0-0.396
Quick Ratio (MRQ)Greater than10.431
Current Ratio (MRQ)Greater than10.743
Debt to Asset Ratio (MRQ)Less than10.330
Debt to Equity Ratio (MRQ)Less than10.542
Return on Equity (MRQ)Greater than0.15-0.020
Return on Assets (MRQ)Greater than0.05-0.012
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Hainan Shuangcheng Pharmaceut based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.647
Ma 20Greater thanMa 505.293
Ma 50Greater thanMa 1005.698
Ma 100Greater thanMa 2006.379
OpenGreater thanClose5.150
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets861,464
Total Liabilities284,606
Total Stockholder Equity525,277
 As reported
Total Liabilities 284,606
Total Stockholder Equity+ 525,277
Total Assets = 861,464

Assets

Total Assets861,464
Total Current Assets203,023
Long-term Assets658,441
Total Current Assets
Cash And Cash Equivalents 3,712
Short-term Investments 87,629
Net Receivables 30,243
Inventory 79,379
Other Current Assets 2,060
Total Current Assets  (as reported)203,023
Total Current Assets  (calculated)203,023
+/- 0
Long-term Assets
Property Plant Equipment 459,072
Intangible Assets 173,795
Long-term Assets Other 12,134
Long-term Assets  (as reported)658,441
Long-term Assets  (calculated)645,000
+/- 13,440

Liabilities & Shareholders' Equity

Total Current Liabilities273,428
Long-term Liabilities11,178
Total Stockholder Equity525,277
Total Current Liabilities
Accounts payable 14,710
Other Current Liabilities 86,863
Total Current Liabilities  (as reported)273,428
Total Current Liabilities  (calculated)101,573
+/- 171,855
Long-term Liabilities
Other Liabilities 11,178
Long-term Liabilities  (as reported)11,178
Long-term Liabilities  (calculated)11,178
+/- 0
Total Stockholder Equity
Common Stock416,631
Other Stockholders Equity -356
Total Stockholder Equity (as reported)525,277
Total Stockholder Equity (calculated)416,275
+/- 109,002
Other
Capital Stock416,631
Common Stock Shares Outstanding 416,631
Net Invested Capital 525,277
Net Tangible Assets 463,441
Net Working Capital -70,405
Property Plant and Equipment Gross 459,072



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312010-12-312009-12-31
> Total Assets 
97,853
252,735
248,058
297,560
860,089
886,651
885,270
870,015
880,128
917,045
912,742
901,805
915,810
943,542
1,174,573
1,270,860
1,404,432
1,550,161
1,441,156
1,454,005
1,317,420
1,165,528
1,196,737
1,359,921
1,346,177
1,377,114
1,302,999
1,330,265
1,182,239
1,120,246
985,259
959,780
937,244
950,983
961,700
953,245
933,220
907,677
853,014
864,613
866,027
854,556
883,387
893,177
895,677
911,019
890,784
903,149
861,464
861,464903,149890,784911,019895,677893,177883,387854,556866,027864,613853,014907,677933,220953,245961,700950,983937,244959,780985,2591,120,2461,182,2391,330,2651,302,9991,377,1141,346,1771,359,9211,196,7371,165,5281,317,4201,454,0051,441,1561,550,1611,404,4321,270,8601,174,573943,542915,810901,805912,742917,045880,128870,015885,270886,651860,089297,560248,058252,73597,853
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
523,271
414,023
372,146
250,780
232,522
204,193
225,387
245,180
207,743
202,085
197,500
149,316
163,520
172,383
165,450
198,727
221,557
228,877
252,394
241,152
252,244
203,023
203,023252,244241,152252,394228,877221,557198,727165,450172,383163,520149,316197,500202,085207,743245,180225,387204,193232,522250,780372,146414,023523,271000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,740
4,160
68,086
47,942
8,808
17,232
42,675
37,601
31,066
6,222
5,797
13,780
11,649
10,474
21,618
14,376
8,275
2,254
12,197
5,920
43,358
3,712
3,71243,3585,92012,1972,2548,27514,37621,61810,47411,64913,7805,7976,22231,06637,60142,67517,2328,80847,94268,0864,16078,740000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
172,410
0
139,978
63,790
84,072
70,339
52,800
96,014
75,746
98,850
94,250
31,480
53,145
69,235
55,403
93,347
119,256
120,811
133,813
126,572
99,005
87,629
87,62999,005126,572133,813120,811119,25693,34755,40369,23553,14531,48094,25098,85075,74696,01452,80070,33984,07263,790139,9780172,410000000000000000000000000000
       Net Receivables 
8,694
6,641
14,860
18,344
13,258
13,282
17,045
31,363
15,903
17,086
10,832
19,717
10,148
22,756
322,147
36,744
34,341
95,345
71,323
60,069
70,304
64,438
66,980
70,368
88,194
239,785
234,371
100,906
76,189
67,625
37,618
60,055
53,299
81,744
57,300
46,023
41,870
36,913
41,238
44,181
34,937
32,618
18,510
32,759
33,228
39,715
34,541
29,320
30,243
30,24329,32034,54139,71533,22832,75918,51032,61834,93744,18141,23836,91341,87046,02357,30081,74453,29960,05537,61867,62576,189100,906234,371239,78588,19470,36866,98064,43870,30460,06971,32395,34534,34136,744322,14722,75610,14819,71710,83217,08615,90331,36317,04513,28213,25818,34414,8606,6418,694
       Other Current Assets 
3,426
14,779
34,830
37,829
42,365
183,853
382,500
379,447
159,423
268,699
51,227
56,960
48,395
79,990
97,901
97,578
100,722
105,747
132,142
100,425
101,754
22,760
41,772
38,196
58,081
19,322
126,967
23,736
205,940
10,151
7,564
3,202
1,608
531
1,220
3,873
2,072
7,750
8,378
1,512
1,969
569
56
1,925
4,326
1,257
3,350
4,373
2,060
2,0604,3733,3501,2574,3261,925565691,9691,5128,3787,7502,0723,8731,2205311,6083,2027,56410,151205,94023,736126,96719,32258,08138,19641,77222,760101,754100,425132,142105,747100,72297,57897,90179,99048,39556,96051,227268,699159,423379,447382,500183,85342,36537,82934,83014,7793,426
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
734,479
727,258
733,050
725,596
716,520
745,502
731,135
710,177
703,698
701,093
693,644
689,106
684,660
671,620
666,800
658,624
649,633
650,905
658,441
658,441650,905649,633658,624666,800671,620684,660689,106693,644701,093703,698710,177731,135745,502716,520725,596733,050727,258734,479000000000000000000000000000000
       Property Plant Equipment 
53,428
54,201
139,940
159,322
172,389
188,068
181,157
196,557
197,387
219,125
231,618
243,976
260,653
264,146
298,706
325,638
381,813
443,222
514,739
564,554
626,189
658,936
624,049
656,166
661,652
679,522
681,397
672,414
660,264
637,817
624,777
614,397
605,461
601,099
589,534
579,765
566,510
541,001
531,187
525,423
514,272
504,732
0
488,694
482,638
471,766
461,200
457,411
459,072
459,072457,411461,200471,766482,638488,6940504,732514,272525,423531,187541,001566,510579,765589,534601,099605,461614,397624,777637,817660,264672,414681,397679,522661,652656,166624,049658,936626,189564,554514,739443,222381,813325,638298,706264,146260,653243,976231,618219,125197,387196,557181,157188,068172,389159,322139,94054,20153,428
       Intangible Assets 
12,056
16,425
1,864
19,861
20,503
1,074
33,172
680
33,470
465
6,229
6,078
5,949
15,652
54,694
82,315
81,229
75,822
75,103
74,396
73,679
89,496
87,911
86,276
84,644
78,817
76,141
73,554
70,877
68,201
96,026
36,128
110,664
115,218
116,648
154,507
154,012
134,377
137,710
142,862
146,602
156,924
158,955
159,148
158,796
164,905
162,647
167,192
173,795
173,795167,192162,647164,905158,796159,148158,955156,924146,602142,862137,710134,377154,012154,507116,648115,218110,66436,12896,02668,20170,87773,55476,14178,81784,64486,27687,91189,49673,67974,39675,10375,82281,22982,31554,69415,6525,9496,0786,22946533,47068033,1721,07420,50319,8611,86416,42512,056
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,831
12,656
11,332
5,419
6,780
7,674
573,604
8,273
8,658
6,816
7,154
9,118
12,232
5,108
6,994
8,703
12,149
13,206
12,134
12,13413,20612,1498,7036,9945,10812,2329,1187,1546,8168,6588,273573,6047,6746,7805,41911,33212,6568,831000000000000000000000000000000
> Total Liabilities 
19,907
94,916
19,827
37,255
35,488
40,802
32,353
35,488
32,401
46,424
35,972
40,388
43,272
49,988
303,146
312,579
425,686
622,556
524,833
539,220
602,331
612,400
649,722
619,768
598,514
615,408
547,691
595,632
468,555
450,559
328,360
311,723
300,903
272,721
293,343
302,598
295,165
309,366
262,853
265,604
279,765
287,805
317,412
315,514
323,416
330,076
309,028
312,075
284,606
284,606312,075309,028330,076323,416315,514317,412287,805279,765265,604262,853309,366295,165302,598293,343272,721300,903311,723328,360450,559468,555595,632547,691615,408598,514619,768649,722612,400602,331539,220524,833622,556425,686312,579303,14649,98843,27240,38835,97246,42432,40135,48832,35340,80235,48837,25519,82794,91619,907
   > Total Current Liabilities 
18,107
93,116
17,727
21,395
19,628
24,942
16,493
20,316
14,623
28,990
18,882
20,873
22,677
22,678
276,255
284,649
392,458
444,667
320,363
245,506
281,964
255,092
306,633
279,323
179,252
200,620
156,976
206,966
111,984
106,835
106,405
107,041
112,935
93,580
114,774
124,599
117,738
129,409
83,467
85,789
100,522
108,412
98,741
94,764
145,487
319,362
298,540
301,895
273,428
273,428301,895298,540319,362145,48794,76498,741108,412100,52285,78983,467129,409117,738124,599114,77493,580112,935107,041106,405106,835111,984206,966156,976200,620179,252279,323306,633255,092281,964245,506320,363444,667392,458284,649276,25522,67822,67720,87318,88228,99014,62320,31616,49324,94219,62821,39517,72793,11618,107
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
50,000
51,540
55,407
5,347
3,804
3,804
0
10,131
10,013
0
0
0
0
0
0000010,01310,13103,8043,8045,34755,40751,54050,00050,0000000000000000000000000000000000000
       Accounts payable 
7,459
3,852
7,072
7,260
7,223
10,651
7,323
7,969
4,518
10,680
9,069
9,277
14,124
8,876
17,751
21,103
12,942
13,172
24,323
13,476
56,413
28,532
44,734
132,890
83,530
80,491
72,950
97,657
20,473
11,786
10,871
8,999
8,160
9,891
10,677
32,007
12,693
15,443
14,213
13,049
14,993
17,159
14,864
13,956
16,996
15,498
15,438
13,905
14,710
14,71013,90515,43815,49816,99613,95614,86417,15914,99313,04914,21315,44312,69332,00710,6779,8918,1608,99910,87111,78620,47397,65772,95080,49183,530132,89044,73428,53256,41313,47624,32313,17212,94221,10317,7518,87614,1249,2779,06910,6804,5187,9697,32310,6517,2237,2607,0723,8527,459
       Other Current Liabilities 
10,648
89,264
10,655
14,135
12,405
14,291
9,170
12,347
10,105
18,310
9,812
11,596
8,553
13,802
8,503
13,546
14,516
86,494
76,040
2,031
15,552
36,559
251,899
146,433
95,721
75,129
84,026
19,158
89,094
41,700
92,432
53,176
102,182
32,738
50,394
18,684
49,604
25,777
58,885
28,472
76,882
50,388
68,190
45,230
82,313
89,965
75,767
68,437
86,863
86,86368,43775,76789,96582,31345,23068,19050,38876,88228,47258,88525,77749,60418,68450,39432,738102,18253,17692,43241,70089,09419,15884,02675,12995,721146,433251,89936,55915,5522,03176,04086,49414,51613,5468,50313,8028,55311,5969,81218,31010,10512,3479,17014,29112,40514,13510,65589,26410,648
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
221,955
204,682
187,967
179,141
178,570
177,999
177,427
179,957
179,386
179,814
179,243
179,393
218,671
220,750
177,929
10,715
10,487
10,180
11,178
11,17810,18010,48710,715177,929220,750218,671179,393179,243179,814179,386179,957177,427177,999178,570179,141187,967204,682221,955000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
187,000
177,000
177,000
167,000
167,000
167,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000167,000167,000167,000177,000177,000187,000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,158
28,259
31,595
10,481
11,747
29,731
44,970
47,329
77,098
74,830
72,403
77,381
84,390
89,760
80,142
0
87,807
86,659
96,302
100,729
106,993
116,087
116,087106,993100,72996,30286,65987,807080,14289,76084,39077,38172,40374,83077,09847,32944,97029,73111,74710,48131,59528,25927,158000000000000000000000000000
> Total Stockholder Equity
77,946
157,819
228,231
260,305
824,601
845,849
852,916
834,527
847,726
870,621
876,770
861,417
872,538
893,554
871,428
958,281
978,746
927,605
916,324
914,785
715,089
553,128
547,015
565,697
575,011
591,397
587,954
572,592
558,956
522,053
512,100
507,387
500,244
546,255
540,995
529,200
520,580
492,925
489,551
502,047
495,145
481,848
484,295
499,270
499,183
513,548
518,764
533,305
525,277
525,277533,305518,764513,548499,183499,270484,295481,848495,145502,047489,551492,925520,580529,200540,995546,255500,244507,387512,100522,053558,956572,592587,954591,397575,011565,697547,015553,128715,089914,785916,324927,605978,746958,281871,428893,554872,538861,417876,770870,621847,726834,527852,916845,849824,601260,305228,231157,81977,946
   Common Stock
5,000
90,000
90,000
90,000
120,000
120,000
120,000
180,000
180,000
180,000
180,000
270,000
270,000
270,000
405,000
419,186
419,186
419,186
419,186
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
405,000
412,000
412,000
412,000
0
414,737
414,737
414,737
414,737
416,184
416,631
416,631416,184414,737414,737414,737414,7370412,000412,000412,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000405,000419,186419,186419,186419,186405,000270,000270,000270,000180,000180,000180,000180,000120,000120,000120,00090,00090,00090,0005,000
   Retained Earnings 
65,778
14,305
77,701
109,775
124,452
138,923
145,990
127,601
140,800
157,056
185,243
169,890
181,011
202,026
179,900
197,331
212,307
229,745
218,463
209,958
6,779
0
0
0
0
0
0
-171,158
-184,803
-221,807
-264,843
-270,521
-277,594
-197,150
-202,411
-214,205
-222,826
-250,480
-253,857
-244,483
-254,513
-270,805
-304,500
-272,619
-274,425
-261,792
-257,287
-253,002
-263,413
-263,413-253,002-257,287-261,792-274,425-272,619-304,500-270,805-254,513-244,483-253,857-250,480-222,826-214,205-202,411-197,150-277,594-270,521-264,843-221,807-184,803-171,1580000006,779209,958218,463229,745212,307197,331179,900202,026181,011169,890185,243157,056140,800127,601145,990138,923124,452109,77577,70114,30565,778
   Capital Surplus 0000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000-63,934-63,93400000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
9
87
-984
-19
-88
-368
-368
-368
-368
-368
-367
-367
-365
-360
0
-368
-369
-358
-356
-347
-356
-356-347-356-358-369-3680-360-365-367-367-368-368-368-368-368-88-19-9848791000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue259,140
Cost of Revenue-77,430
Gross Profit181,710181,710
 
Operating Income (+$)
Gross Profit181,710
Operating Expense-287,589
Operating Income-28,449-105,879
 
Operating Expense (+$)
Research Development14,150
Selling General Administrative129,824
Selling And Marketing Expenses-
Operating Expense287,589143,974
 
Net Interest Income (+$)
Interest Income97
Interest Expense-10,147
Other Finance Cost-210
Net Interest Income-10,260
 
Pretax Income (+$)
Operating Income-28,449
Net Interest Income-10,260
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,932-28,449
EBIT - interestExpense = -10,147
11,012
21,159
Interest Expense10,147
Earnings Before Interest and Taxes (EBIT)--2,786
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-12,932
Tax Provision--2,446
Net Income From Continuing Ops-10,486-10,486
Net Income11,012
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-10,260
 

Technical Analysis of Hainan Shuangcheng Pharmaceut
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hainan Shuangcheng Pharmaceut. The general trend of Hainan Shuangcheng Pharmaceut is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hainan Shuangcheng Pharmaceut's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hainan Shuangcheng Pharmaceut.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.66 < 6.78 < 6.88.

The bearish price targets are: 4.53 > 3.91 > 3.67.

Tweet this
Hainan Shuangcheng Pharmaceut Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hainan Shuangcheng Pharmaceut. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hainan Shuangcheng Pharmaceut Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hainan Shuangcheng Pharmaceut. The current macd is -0.24925531.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hainan Shuangcheng Pharmaceut price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hainan Shuangcheng Pharmaceut. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hainan Shuangcheng Pharmaceut price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hainan Shuangcheng Pharmaceut Daily Moving Average Convergence/Divergence (MACD) ChartHainan Shuangcheng Pharmaceut Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hainan Shuangcheng Pharmaceut. The current adx is 26.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hainan Shuangcheng Pharmaceut shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Hainan Shuangcheng Pharmaceut Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hainan Shuangcheng Pharmaceut. The current sar is 4.61856143.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hainan Shuangcheng Pharmaceut Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hainan Shuangcheng Pharmaceut. The current rsi is 46.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Hainan Shuangcheng Pharmaceut Daily Relative Strength Index (RSI) ChartHainan Shuangcheng Pharmaceut Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hainan Shuangcheng Pharmaceut. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hainan Shuangcheng Pharmaceut price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hainan Shuangcheng Pharmaceut Daily Stochastic Oscillator ChartHainan Shuangcheng Pharmaceut Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hainan Shuangcheng Pharmaceut. The current cci is -12.74437021.

Hainan Shuangcheng Pharmaceut Daily Commodity Channel Index (CCI) ChartHainan Shuangcheng Pharmaceut Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hainan Shuangcheng Pharmaceut. The current cmo is 3.40251194.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hainan Shuangcheng Pharmaceut Daily Chande Momentum Oscillator (CMO) ChartHainan Shuangcheng Pharmaceut Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hainan Shuangcheng Pharmaceut. The current willr is -37.60683761.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hainan Shuangcheng Pharmaceut is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hainan Shuangcheng Pharmaceut Daily Williams %R ChartHainan Shuangcheng Pharmaceut Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hainan Shuangcheng Pharmaceut.

Hainan Shuangcheng Pharmaceut Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hainan Shuangcheng Pharmaceut. The current atr is 0.27352602.

Hainan Shuangcheng Pharmaceut Daily Average True Range (ATR) ChartHainan Shuangcheng Pharmaceut Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hainan Shuangcheng Pharmaceut. The current obv is 724,204,871.

Hainan Shuangcheng Pharmaceut Daily On-Balance Volume (OBV) ChartHainan Shuangcheng Pharmaceut Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hainan Shuangcheng Pharmaceut. The current mfi is 49.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hainan Shuangcheng Pharmaceut Daily Money Flow Index (MFI) ChartHainan Shuangcheng Pharmaceut Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hainan Shuangcheng Pharmaceut.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Hainan Shuangcheng Pharmaceut Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hainan Shuangcheng Pharmaceut based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.647
Ma 20Greater thanMa 505.293
Ma 50Greater thanMa 1005.698
Ma 100Greater thanMa 2006.379
OpenGreater thanClose5.150
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hainan Shuangcheng Pharmaceut with someone you think should read this too:
  • Are you bullish or bearish on Hainan Shuangcheng Pharmaceut? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hainan Shuangcheng Pharmaceut? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hainan Shuangcheng Pharmaceut

I send you an email if I find something interesting about Hainan Shuangcheng Pharmaceut.


Comments

How you think about this?

Leave a comment

Stay informed about Hainan Shuangcheng Pharmaceut.

Receive notifications about Hainan Shuangcheng Pharmaceut in your mailbox!